Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2022		373,873,683
Balance at beginning of period at Dec. 31, 2022	$ 1,902,677	$ 11	$ 3,155,748	$ (83,382)	$ (1,169,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued in connection with equity awards (in shares)		4,061,015
Stock issued in connection with equity awards	2,974		2,974
Shares withheld related to net share settlement (in shares)		(1,281,849)
Shares withheld related to net share settlement	(19,167)		(19,167)
Repurchase of Class A common stock (in shares)		(5,396,617)
Repurchase of Class A common stock	(76,358)		(76,358)
Stock-based compensation	82,966		82,966
Total other comprehensive loss, net of tax	10,006			10,006
Net income	(4,518)				(4,518)
Balance at end of period (in shares) at Mar. 31, 2023		371,256,232
Balance at end of period at Mar. 31, 2023	1,898,580	$ 11	3,146,163	(73,376)	(1,174,218)
Balance at beginning of period (in shares) at Dec. 31, 2023		339,886,712
Balance at beginning of period at Dec. 31, 2023	1,256,329	$ 11	2,134,581	(65,274)	(812,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued in connection with equity awards (in shares)		3,936,518
Stock issued in connection with equity awards	23,429		23,429
Shares withheld related to net share settlement (in shares)		(1,397,947)
Shares withheld related to net share settlement	(80,144)		(80,144)
Repurchase of Class A common stock (in shares)		(13,466,397)
Repurchase of Class A common stock	(752,224)		(752,224)
Stock-based compensation	95,253		95,253
Total other comprehensive loss, net of tax	(18,622)			(18,622)
Net income	236,183				236,183
Balance at end of period (in shares) at Mar. 31, 2024		328,958,886
Balance at end of period at Mar. 31, 2024	$ 760,204	$ 11	$ 1,420,895	$ (83,896)	$ (576,806)